Chiswili Yves Chabu
Dr. Chabu received his PhD from the University of Oregon/Howard Hughes Medical Institute (HHMI) where he worked on understanding the molecular mechanisms that control cortical polarity, stemness, and mitotic potential of neuroblasts. Following completion of his PhD, Dr. Chabu went to Yale School of Medicine/HHMI for his Postdoctoral fellowship. At Yale, he used complementing Drosophila and mouse models of oncogenic RAS tumors and discovered novel intercellular signaling dynamics explaining how oncogenic RAS drives tumor overgrowth. In 2017, Dr. Chabu started his independent position at the University of Missouri.
His laboratory research interests include mechanistic dissection of the role of extracellular vesicles (EV) in tissue growth control during organ development and cancer progression. In addition, Dr. Chabu’s team is exploring EV-based minimally invasive biomarkers for early cancer detection, prognostic, and patient stratification in lung cancer.
His laboratory research interests include mechanistic dissection of the role of extracellular vesicles (EV) in tissue growth control during organ development and cancer progression. In addition, Dr. Chabu’s team is exploring EV-based minimally invasive biomarkers for early cancer detection, prognostic, and patient stratification in lung cancer.
